October 3 - 6, 2019   Chicago Marriott Downtown Magnificent Mile

Non-CME Educational Activities

All events are scheduled during times that do not conflict with Symposium CME educational programming.

These optional non-CME educational activity and are not approved for CME or continuing education credit. The content of these optional non-CME activities and opinions expressed by presenters are those of the sponsor or presenters.

Details will be available here soon.

New Survival Data for a Treatment Option Approved for Patients With HR+, HER2- Metastatic Breast Cancer

Friday, October 4, 2019 • 12:15 p.m. - 1:30 p.m.
© Lilly USA, LLC 2019. All rights reserved.

PDf Flyer »

Two Considerations in the Management of HR+/HER2- mBC: The Importance of PIK3CA Mutations and the Arrival of OS Data With a CDK4/6 Inhibitor

Saturday, October 5, 2019 • 7:00 a.m. - 8:15 a.m.

PDf Flyer »

In the HER2+ Early Breast Cancer Setting

Saturday, October 5, 2019 • 12:15 p.m. - 1:30 p.m.

PDf Flyer »

© 2018 Robert H. Lurie Comprehensive Cancer Center